Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
Lüchtenborg M, Morris EJA, Tataru D, Coupland VH, Smith A, Milne RL, Te Marvelde L, Baker D, Young J, Turner D, Nishri D, Earle C, Shack L, Gavin A, Fitzpatrick D, Donnelly C, Lin Y, Møller B, Brewster DH, Deas A, Huws DW, White C, Warlow J, Rashbass J, Peake MD. Lüchtenborg M, et al. Among authors: warlow j. Thorax. 2018 Apr;73(4):339-349. doi: 10.1136/thoraxjnl-2017-210362. Epub 2017 Oct 27. Thorax. 2018. PMID: 29079609 Free PMC article.
Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
Eden M, Harrison S, Griffin M, Lambe M, Pettersson D, Gavin A, Brewster DH, Lin Y, Johannesen TB, Milne RL, Farrugia H, Nishri D, King MJ, Huws DW, Warlow J, Turner D, Earle CC, Peake M, Rashbass J. Eden M, et al. Among authors: warlow j. Cancer Epidemiol. 2019 Feb;58:184-192. doi: 10.1016/j.canep.2018.10.019. Epub 2019 Jan 9. Cancer Epidemiol. 2019. PMID: 30639877
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Araghi M, Fidler-Benaoudia M, Arnold M, Rutherford M, Bardot A, Ferlay J, Bucher O, De P, Engholm G, Gavin A, Kozie S, Little A, Møller B, St Jacques N, Tervonen H, Walsh P, Woods R, O'Connell DL, Baldwin D, Elwood M, Siesling S, Bray F, Soerjomataram I; ICBP SURVMARK-2 Local Leads; ICBP SURVMARK-2 Academic Reference Group; ICBP Clinical Committee–Lung; ICBP SurvMark-2 Academic Reference GroupICBP SurvMark-2 academic reference group; ICBP Clinical Committee – LungICBP clinical Committee – lung. Araghi M, et al. Thorax. 2022 Apr;77(4):378-390. doi: 10.1136/thoraxjnl-2020-216555. Epub 2021 Jul 19. Thorax. 2022. PMID: 34282033 Free article.
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S, Swann R, Johnson SA, Barclay ME, Abd Elkader H, Alvi R, Barisic A, Bucher O, Clark GRC, Creighton N, Danckert B, Denny CA, Donnelly DW, Dowden JJ, Finn N, Fox CR, Fung S, Gavin AT, Gomez Navas E, Habbous S, Han J, Huws DW, Jackson CGCA, Jensen H, Kaposhi B, Kumar SE, Little AL, Lu S, McClure CA, Møller B, Musto G, Nilssen Y, Saint-Jacques N, Sarker S, Te Marvelde L, Thomas RS, Thomas RJS, Thomson CS, Woods RR, Zhang B, Lyratzopoulos G; ICBP Module 9 Emergency Presentations Working Group. McPhail S, et al. Lancet Oncol. 2022 May;23(5):587-600. doi: 10.1016/S1470-2045(22)00127-9. Epub 2022 Apr 6. Lancet Oncol. 2022. PMID: 35397210 Free PMC article.
Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, Lyons RA, Rolles M, Torabi F, Warlow J, Morris ERA, Lawler M, Huws DW. Greene G, et al. Among authors: warlow j. Br J Cancer. 2022 Aug;127(3):558-568. doi: 10.1038/s41416-022-01830-6. Epub 2022 May 2. Br J Cancer. 2022. PMID: 35501391 Free PMC article.
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S, Barclay ME, Johnson SA, Swann R, Alvi R, Barisic A, Bucher O, Creighton N, Denny CA, Dewar RA, Donnelly DW, Dowden JJ, Downie L, Finn N, Gavin AT, Habbous S, Huws DW, May L, McClure CA, Møller B, Musto G, Nilssen Y, Saint-Jacques N, Sarker S, Shack L, Tian X, Thomas RJS, Thomson CS, Wang H, Woods RR, You H, Lyratzopoulos G; ICBP Module 9 Chemotherapy Group. McPhail S, et al. Lancet Oncol. 2024 Mar;25(3):338-351. doi: 10.1016/S1470-2045(24)00031-7. Lancet Oncol. 2024. PMID: 38423048 Free article.
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S, Barclay ME, Swann R, Johnson SA, Alvi R, Barisic A, Bucher O, Creighton N, Denny CA, Dewar RA, Donnelly DW, Dowden JJ, Downie L, Finn N, Gavin AT, Habbous S, Huws DW, Kumar SE, May L, McClure CA, Morrison DS, Møller B, Musto G, Nilssen Y, Saint-Jacques N, Sarker S, Shack L, Tian X, Thomas RJ, Wang H, Woods RR, You H, Zhang B, Lyratzopoulos G; ICBP Module 9 Radiotherapy Group. McPhail S, et al. Lancet Oncol. 2024 Mar;25(3):352-365. doi: 10.1016/S1470-2045(24)00032-9. Lancet Oncol. 2024. PMID: 38423049 Free article.
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project - international benchmarking of childhood cancer survival by stage.
Lopez-Cortes A, Didonè F, Botta L, Hjalgrim LL, Jakab Z, Canete Nieto A, Stiller C, Zeller B, Gatta G, Pritchard-Jones K; BENCHISTA Project Working Group. Lopez-Cortes A, et al. Front Oncol. 2023 Aug 22;13:1232451. doi: 10.3389/fonc.2023.1232451. eCollection 2023. Front Oncol. 2023. PMID: 37675230 Free PMC article.